Biosymetrics Is A Phenomics Driven Drug Discovery Company Based In New Yorkfounded In 2015The Company Focuses On Integrating Clinical And Experimental Data Through Machine Learning To Enhance Precision Medicinebiosymetrics Serves The Pharmaceutical And Healthcare Sectors By Utilizing Ai Driven Target Discovery And Precision Medicine Programs The Company Offers A Technology Platform Called Augustaa Cwhich Performs Advanced Data Pre Processing And Integrated Machine Learning On Complex Biomedical Datathis Platform Enables The Integration Of Various Data Typesincluding Biologicalclinicalgenomicsand Drug Development Datafor Efficient Analyticsbiosymetrics Also Employs A Patent Pending Technology Known As Contingent Aia C To Improve Bias Detection And Correction During Machine Learning Pre Processingleading To Faster And More Accurate Predictive Results In Drug Discovery Biosymetrics Collaborates With Prominent Healthcare And Life Science Organizationsincluding Northwell Healthjanssensema4And Mtsinaito Further Its Research And Development Effortsthe Company Has Raised $4 88 Million In Funding And Operates With A Dedicated Team Of 11 50 Employees
